Disordered Purinergic Signaling Inhibits Pathological Angiogenesis in Cd39/Entpd1-Null Mice

This publication has 31 references indexed in Scilit:

• Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
  The Journal of Experimental Medicine, 2007
• A2A adenosine receptor protects tumors from antitumor T cells
  Proceedings of the National Academy of Sciences, 2006
• RanBPM associates with CD39 and modulates ecto-nucleotidase activity
  Biochemical Journal, 2006
• RanBPM Is a Phosphoprotein That Associates with the Plasma Membrane and Interacts with the Integrin LFA-1
  Journal of Biological Chemistry, 2004
• Integrins in angiogenesis: multitalented molecules in a balancing act
  Cell and tissue research, 2003
• Regulation of G Protein–Coupled Receptor Signaling by Scaffold Proteins
  Circulation Research, 2002
• Activation of Ras/Erk Pathway by a Novel MET-interacting Protein RanBPM
  Published by Elsevier ,2002
• Seven-transmembrane receptors
  Nature Reviews Molecular Cell Biology, 2002
• Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins
  Nature Medicine, 2002
• Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
  Published by Elsevier ,1996